What does Samrat Pharmachem Limited do?

Samrat Pharmachem Limited (SAMRATPH.BO) operates in the Chemicals - Specialty industry within the Basic Materials sector. Full company description, peers, and segment breakdown are on the page above.

What is SAMRATPH.BO's market cap?

Samrat Pharmachem Limited (SAMRATPH.BO) has a market capitalization of approximately $744.5 million, as of August 28, 2026, based on the most recent share price and shares outstanding.

Does SAMRATPH.BO pay a dividend?

Yes — Samrat Pharmachem Limited (SAMRATPH.BO) pays a dividend annually, with a trailing-twelve-month yield of 0.42%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is SAMRATPH.BO profitable?

Samrat Pharmachem Limited (SAMRATPH.BO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

SAMRATPH.BO

Samrat Pharmachem Limited

BSE·Chemicals, Specialty · Basic Materials

₹240.95₹4.65−1.89%

Market cap₹744.46M·Market closed·Aug 28 9:57 AM UTC

Price Chart

₹240.95−₹4.65 (−1.89%)today

+22.78%CAGR +4.19%

Select date range

FromTo

Jan 23, 2002Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.42%

Annual Dividend (FWD)₹1.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend₹1.00

Ex-Dividend DateSep 18

Payment DateOct 16

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 28

Last Report DateMay 28

Reported vs Estimate−₹6.59

Earnings Surprise—

FinancialsFinancials Tab

Revenue₹2.94B

Net Income−₹22.07M

Net Margin−0.8%

Operating Cash Flow₹0.00

Capital Expenditures₹0.00

Free Cash Flow₹0.00

Return on Equity−3.2%

Return on Invested Capital0.0%

Net Debt₹43.42M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for SAMRATPH.BO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how SAMRATPH.BO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SAMRATPH.BO and 80,000+ other tickers.

About Samrat Pharmachem Limited

Samrat Pharmachem Ltd. is a company focused on the production and sale of various chemical compounds. Its product offerings feature substances like 3-5–Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. Lalit Damodar Mehta founded the enterprise on June 16, 1992, and it maintains its primary offices in Mumbai, India.

CEO: Lalit Damodar Mehta
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: BSE
Employees: 32
Website: www.samratpharmachem.com

Peers

Archit Organosys Limited

Latest News

News Tab

No recent news available.

Frequently Asked Questions About SAMRATPH.BO

What does Samrat Pharmachem Limited do?: Samrat Pharmachem Limited (SAMRATPH.BO) operates in the Chemicals - Specialty industry within the Basic Materials sector. Full company description, peers, and segment breakdown are on the page above.
What is SAMRATPH.BO's market cap?: Samrat Pharmachem Limited (SAMRATPH.BO) has a market capitalization of approximately $744.5 million, as of August 28, 2026, based on the most recent share price and shares outstanding.
Does SAMRATPH.BO pay a dividend?: Yes — Samrat Pharmachem Limited (SAMRATPH.BO) pays a dividend annually, with a trailing-twelve-month yield of 0.42%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is SAMRATPH.BO profitable?: Samrat Pharmachem Limited (SAMRATPH.BO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.